Whooping cough vaccine in pregnancy to protect babies
Part of Infections, Lungs & breathing clinical trials.
This study tests a new type of whooping cough vaccine given to pregnant women to see if it helps protect their babies from whooping cough in the first months of life. The vaccine is given during pregnancy, and then the baby's immune response is checked up to 15–18 months old.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant, between 20 and 45 years old, and between 20 and 32 weeks along.
- You are generally healthy with no major medical conditions like diabetes, high blood pressure, or immune disorders.
- You have not had a whooping cough or tetanus shot recently (within the past year).
- Your pregnancy is considered low-risk and you are carrying one baby.
- You are willing to receive a study vaccine and give blood samples.
- You agree to let your baby receive routine vaccines and give blood samples after birth.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combined vaccine that protects against whooping cough, diphtheria, and tetanus for people aged 10 and older. It aims to see if the vaccine is safe and how well it works to boost immunity in teens and adults.
This trial tests a new combined vaccine for diphtheria, tetanus, and whooping cough (pertussis) in children of different ages. It aims to see if the vaccine is safe and how well it works, helping to protect against these serious diseases.
This study tests a lower-dose vaccine that protects against diphtheria, tetanus, and whooping cough. It aims to see if the vaccine is safe and how well it works for people aged 6 and older, possibly offering a booster with fewer side effects.
This study checks if the protection from an earlier vaccine (against whooping cough, diphtheria, and tetanus) lasts over time. Participants from a previous study will give blood samples to measure their immune response.
This trial tests a new vaccine that protects against diphtheria, tetanus, and pertussis (whooping cough). It is for healthy infants who are about 2 months old and live permanently in the area. The goal is to see if the vaccine is safe and works well.
This study tests whether giving two vaccines—one for whooping cough (Tdap) and one for RSV—at the same time is safe and effective compared to giving them separately during pregnancy. It may help protect your baby from both diseases early in life.
Hear when a new Pertussis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.